Abstract
Background: Diabetes is the leading cause of end-stage kidney disease (ESKD) worldwide and is prevalent amongst Asians. The glucokinase regulator (GCKR) modulates glucokinase activity by forming an inhibitory complex and influences multiple metabolic pathways. Some studies have reported associations of GCKR polymorphisms with renal function and chronic kidney disease, however, the association of rs1260326 polymorphism with albuminuria and risk of ESKD remains unclear.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
